![Norman LaFrance](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Norman LaFrance
Företagsledare/Principal på
YMAS THER
Profil
Norman D.
LaFrance is currently Chief Development Officer at Y-mAbs Therapeutics, Inc. since 2024.
Former positions include Chief Medical Officer & Senior Vice President at Plus Therapeutics, Inc. from 2021 to 2024; Chief Medical Officer & Senior Vice President at Jubilant Pharma Ltd. from 2012 to 2022; Global Chief Medical Officer at Zevacor Pharma, Inc. from 2010 to 2012; Chief Medical Officer & SVP-Clinical Development at Molecular Insight Pharmaceuticals, Inc. from 2007 to 2010; VP-Global Pharmaceutical Research & Development at Bausch & Lomb, Inc. from 2005 to 2007; and Senior Vice President-Medical & Regulatory Affairs at Celltech Americas, Inc. from 2002 to 2005.
Education includes undergraduate and graduate degrees from Rensselaer Polytechnic Institute and a doctorate from the University of Arizona.
Aktiva positioner av Norman LaFrance
| Företag | Position | Start |
|---|---|---|
| YMAS THER | Företagsledare/Principal | 2024-06-05 |
Tidigare kända positioner av Norman LaFrance
| Företag | Position | Slut |
|---|---|---|
| CERENOME, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2024-06-11 |
Jubilant Pharma Ltd.
 Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-01 |
Jubilant Pharma Holdings, Inc.
 Jubilant Pharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Teknisk/Vetenskaplig/F&U Direktör | 2021-11-01 |
Zevacor Pharma, Inc.
 Zevacor Pharma, Inc. Medical DistributorsDistribution Services Distributes and develops molecular imaging solutions | Teknisk/Vetenskaplig/F&U Direktör | 2012-01-01 |
Molecular Insight Pharmaceuticals, Inc.
 Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Teknisk/Vetenskaplig/F&U Direktör | 2010-11-05 |
Norman LaFrances utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
65
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Bausch & Lomb, Inc.
 Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Manufactures and supplies contact lenses | Health Technology |
Molecular Insight Pharmaceuticals, Inc.
Molecular Insight Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Develops and commercializes innovative molecular imaging pharmaceuticals | Health Services |
Rensselaer Polytechnic Institute
 Rensselaer Polytechnic Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Plus Therapeutics, Inc.
 Plus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops radio therapeutics products | Health Technology |
Celltech Americas, Inc. | |
Zevacor Pharma, Inc.
Zevacor Pharma, Inc. Medical DistributorsDistribution Services Distributes and develops molecular imaging solutions | Distribution Services |
Jubilant Pharma Ltd.
Jubilant Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Jubilant Pharma Holdings, Inc.
Jubilant Pharma Holdings, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
